Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Considering a clinical trial may seem like a daunting prospect, but sometimes it can be the smartest strategy. Here are some basic questions to help you make a good decision. 1.
Ask the Doctor Question: How does the new BTKi Loxo-305 compare so far in clinical trials vs. the present approved BTKis in terms of side effects? Answer: We covered the oral presentation
Communication is critical among patients, caregivers, and doctors to optimize the understanding of treatment options, risks, benefits, compliance, success, and recognition of adverse reactions.
Research & Clinical Trials Concerning COVID-19 Only All the advancements in preventing and treating COVID-19 are due to the brave volunteers who entered clinical trials for vaccines, monoclonal antibodies for both
At the annual meeting of the European Hematology Association (EHA) 2021, our own Dr. Brian Koffman spoke with Dr. Jennifer Woyach, a professor of medicine and hematologist at the James Cancer Center of the Ohio State University, about 2 ongoing clinical trials that are currently recruiting patients with CLL.
Join CLL Society for this important Ed Forum to learn the basics about testing across the span of your CLL journey. At the time of diagnosis, find out which tests should be performed, which might be avoided, and why. Before starting your first treatment, and prior to every subsequent treatment, know which tests you absolutely must have, which we strongly advise through CLL Society’s Test Before Treat™ campaign. Two patients will share their stories about the importance of getting the right tests completed prior to choosing treatment. Finally, learn how CLL is monitored over time, and how the evolving role of MRD (measurable residual disease) testing may help determine when to stop therapy in CLL.
While this is not a CLL specific topic, it is research on a subject that is critical to our mission at CLL Society to be an inclusive organization and encourage diversity in all cancer clinical trials.
The use of CT scans is an effective diagnostic method to assess internal organs and disease status, as well as the effect of treatment in cancer patients. CT scans, with or
CLL Clinical Trials CLL is not a solved problem, but we do have excellent treatments. It was only through clinical trials that the safety and efficacy of existing therapies was proven, and the
One click to our most popular content.
